Kazakhstan spoke about the third phase of trials of its COVID vaccine

“The exact date for the completion of the third phase of clinical trials of the Kazakhstani vaccine QazCovid-In is July 9, 2021.

After that, there is a lot of work to process the data received from 3 thousand volunteers, which will take about 20 calendar days.

After that, our report in full will be submitted to the Ministry of Health for consideration, ”TASS quotes Kunsulu Zakarya, Director General of the Research Institute for Biological Safety Problems, in which this drug is created.

According to her, mass vaccination with QazCovid-In is planned to begin at the end of April.

Earlier it was reported that in Kazakhstan, the number of seriously ill COVID-19 in March increased by 32%.